FDA Warning Letter — Xiamen Kang Zhongyuan Biotechnology Co., Ltd.
The FDA took a Warning Letter action against Xiamen Kang Zhongyuan Biotechnology Co., Ltd. on Apr 3, 2026 (Xiamen, China). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Xiamen Kang Zhongyuan Biotechnology Co., Ltd.
- Date
- Apr 3, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Center
- CDER
- Location
- Xiamen (China)